ZC3H13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.515200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.912200E-01
Normal-vs-Stage2
3.433000E-01
Normal-vs-Stage3
2.250200E-02
Normal-vs-Stage4
6.891000E-01
Stage1-vs-Stage2
3.301200E-01
Stage1-vs-Stage3
2.611600E-02
Stage1-vs-Stage4
4.551800E-01
Stage2-vs-Stage3
1.564040E-01
Stage2-vs-Stage4
8.442400E-02
Stage3-vs-Stage4
7.739600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.912200E-01
Normal-vs-AfricanAmerican
7.008000E-01
Normal-vs-Asian
3.552200E-01
Caucasian-vs-AfricanAmerican
4.271800E-01
Caucasian-vs-Asian
6.568000E-01
AfricanAmerican-vs-Asian
4.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.970000E-01
Normal-vs-Female
4.361000E-01
Male-vs-Female
4.604200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.418200E-01
Normal-vs-Age(41-60Yrs)
6.322200E-01
Normal-vs-Age(61-80Yrs)
2.591400E-01
Normal-vs-Age(81-100Yrs)
1.622770E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.115000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.559900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.706600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.765900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.569400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.525200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.374180E-01
Normal-vs-Daily Drinker
1.963580E-02
Normal-vs-Weekly Drinker
3.633400E-01
Normal-vs-Occasional Drinker
6.211400E-01
Normal-vs-Social Drinker
7.956400E-01
Non Drinker-vs-Daily Drinker
1.824160E-01
Non Drinker-vs-Weekly Drinker
6.287200E-01
Non Drinker-vs-Occasional Drinker
1.585560E-01
Non Drinker-vs-Social Drinker
8.244500E-02
Daily Drinker-vs-Weekly Drinker
1.412570E-01
Daily Drinker-vs-Occasional Drinker
2.922200E-02
Daily Drinker-vs-Social Drinker
2.628100E-02
Weekly Drinker-vs-Occasional Drinker
5.041800E-01
Weekly Drinker-vs-Social Drinker
3.473800E-01
Occasional Drinker-vs-Social Drinker
7.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.028200E-02
Normal-vs-Grade 2
1.664160E-02
Normal-vs-Grade 3
1.528430E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.183200E-01
Grade 1-vs-Grade 3
7.877600E-01
Grade 1-vs-Grade 4
7.028200E-02
Grade 2-vs-Grade 3
5.999800E-01
Grade 2-vs-Grade 4
1.664160E-02
Grade 3-vs-Grade 4
1.528430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.399600E-01
Normal-vs-NonDiabetic
2.710000E-01
Diabetic-vs-NonDiabetic
7.349800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.041900E-02
Normal-vs-NoPancreatitis
3.112000E-01
Pancreatitis-vs-NoPancreatitis
2.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.597400E-01
Normal-vs-N1
3.739000E-01
N0-vs-N1
8.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.366600E-01
Normal-vs-TP53-NonMutant
5.303000E-01
TP53-Mutant-vs-TP53-NonMutant
8.060200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
